Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01976741
Title Phase I Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Bayer
Indications

lung adenocarcinoma

lung non-small cell carcinoma

lung squamous cell carcinoma

urinary bladder cancer

head and neck cancer

Advanced Solid Tumor

Therapies

Rogaratinib

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU

Additional content available in CKB BOOST